福泰制药(VRTX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

VRTX 福泰制药

休市中 07-24 16:00:00 EDT

477.36

+4.27

+0.90%

盘后477.99

+0.63+0.13%

19:57 EDT

最高484.00	最低472.58	成交量125.42万
今开476.05	昨收473.09	日振幅2.42%
总市值1,211亿	流通市值1,211亿	总股本2.54亿
成交额6.00亿	换手率0.49%	流通股本2.54亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"VRTX","market":"US","secType":"STK","nameCN":"福泰制药","latestPrice":477.36,"timestamp":1784923200000,"preClose":473.09,"halted":0,"volume":1254156,"hourTrading":{"tag":"盘后","latestPrice":477.99,"preClose":477.36,"latestTime":"19:57 EDT","volume":122628,"amount":58538917.125,"timestamp":1784937445315,"change":0.63,"changeRate":0.00132,"amplitude":0.003687},"delay":0,"changeRate":0.00902576676742277,"floatShares":253718831,"shares":253718831,"eps":16.85,"marketStatus":"休市中","change":4.27,"latestTime":"07-24 16:00:00 EDT","open":476.05,"high":483.9999,"low":472.575,"amount":600132746.79588,"amplitude":0.02415,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":16.85,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1785139200000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":473.09,"preHourTrading":{"tag":"盘前","latestPrice":476.3,"preClose":473.09,"latestTime":"09:29 EDT","volume":471,"amount":224329.11402,"timestamp":1784899799999,"change":3.21,"changeRate":0.006785,"amplitude":0.0223},"postHourTrading":{"tag":"盘后","latestPrice":477.99,"preClose":477.36,"latestTime":"19:57 EDT","volume":122628,"amount":58538917.125,"timestamp":1784937445315,"change":0.63,"changeRate":0.00132,"amplitude":0.003687},"volumeRatio":0.9840203671123855,"impliedVol":0.3928,"impliedVolPercentile":0.8048},"requestUrl":"/m/hq/s/VRTX","defaultTab":"news","newsList":[{"id":"2651117599","title":"Vertex(VRTX)百亿美元收购罕见病药企 拓宽内分泌管线布局","url":"https://stock-news.laohu8.com/highlight/detail?id=2651117599","media":"金吾财讯","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651117599?lang=zh_cn&edition=full","pubTime":"2026-07-13 22:10","pubTimestamp":1783951848,"startTime":"0","endTime":"0","summary":"金吾财讯 | Vertex Pharmaceuticals  与 Crinetics Pharmaceuticals  共同披露收购协议，企业将以每股 85 美元现金完成标的全额收购，交易对应 Crinetics 整体股权价值约 100 亿美元，扣除标的账面现金后净交易对价 88 亿美元，交易预计 2026 年第三季度完成，消息落地后 Crinetics 盘后股价实现翻倍上涨。Vertex 计划依托自有现金搭配债务工具完成交易资金筹措，美国银行、摩根士丹利提供 45 亿美元全额过渡性融资，收购落地后企业罕见病内分泌赛道产品矩阵将实现大幅扩容。","market":"hk","thumbnail":"https://static.szfiu.com/news/20210625/NjJmZjg2MTAxNTM3NTgyMzkx.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210625/NjJmZjg2MTAxNTM3NTgyMzkx.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"302497","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ9MQY76.HKD","LU0256863811.USD","IE00B19Z3581.USD","SG9999001176.SGD","BK4007","IE00B2B36J28.USD","LU0757428866.USD","IE0009355771.USD","IE00B894F039.SGD","LU1093756325.SGD","LU2362540622.SGD","LU2362541513.USD","LU1778281490.HKD","LU1069344957.HKD","IE00B4R5TH58.HKD","LU0234570918.USD","LU0061475181.USD","PBE","LU0566484027.USD","IBB","IE00BJT1NW94.SGD","BBH","LU1035775433.USD","LU2417539215.USD","IBBQ","LU0432979614.USD","CRNX","LU0889565916.HKD","IE0002270589.USD","LU2462157665.USD","IE00BFTCPJ56.SGD","LU2237438978.USD","BK4585","SG9999013999.USD","LU0079474960.USD","LU0109394709.USD","SG9999001176.USD","LU1093756168.USD","LU2362541273.HKD","VRTX","LU2456880835.USD","IDNA","IE0002141913.USD","LU1674673428.USD","VERX","BIB","BK4532","IE00B19Z9Z06.USD","BK4588","LU1585245621.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650760159","title":"福泰制药百亿美元并购透露了什么讯号？","url":"https://stock-news.laohu8.com/highlight/detail?id=2650760159","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650760159?lang=zh_cn&edition=full","pubTime":"2026-07-11 22:55","pubTimestamp":1783781749,"startTime":"0","endTime":"0","summary":"01百亿美元级现金并购的底气福泰制药2025年全年营收120.01亿美元，同比增长9%，非GAAP净利润47.5亿美元，毛利率维持85%以上高位，账面现金及有价证券超过123亿美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1783569458583958068","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK4139","IE00BZ9MQY76.HKD","BK4532","IE00B19Z9Z06.USD","LU2324357040.USD","LU0061475181.USD","BK4567","LU1093756325.SGD","LU0289739699.SGD","IBB","IE0009355771.USD","LU2462157665.USD","IE00B2B36J28.USD","LU0234570918.USD","IE0002141913.USD","IE00B19Z9P08.USD","LU0320765992.SGD","IE00B894F039.SGD","IE00BJT1NW94.SGD","LU1035775433.USD","XMMO","LU1778281490.HKD","IDNA","IE00BJJMRZ35.SGD","SG9999001176.USD","MYLD","VRTX","IE00BFTCPJ56.SGD","LU1093756168.USD","BIB","LU0079474960.USD","IE00B4R5TH58.HKD","BBH","IE0002270589.USD","LU1585245621.USD","IE00B19Z3581.USD","LU2236285917.USD","LU2417539215.USD","SGXZ57979304.SGD","LU2362540622.SGD","SG9999001176.SGD","CALF","KCE","LU1069344957.HKD","PBE","LU0823416689.USD","LU0058720904.USD","BK4588","IBBQ","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157031563","title":"异动解读｜福泰制药盘中下跌3.24%，百亿美元收购Crinetics引发市场消化压力","url":"https://stock-news.laohu8.com/highlight/detail?id=1157031563","media":"行情直击","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1157031563?lang=zh_cn&edition=full","pubTime":"2026-07-09 01:37","pubTimestamp":1783532262,"startTime":"0","endTime":"0","summary":"7月8日，福泰制药盘中下跌3.24%，报505.32美元/股，成交额4.09亿美元。消息面上，福泰制药于7月7日宣布将以每股85美元现金收购Crinetics Pharmaceuticals，交易总股权价值约100亿美元，较后者收盘价溢价102%，为公司史上最大规模收购。福泰制药预计收购将于第三季度完成，2029年方可对调整后营业利润产生正贡献。此前交易公布当日福泰制药已跌超2%，当前跌幅为市场对收购成本及整合风险的进一步定价。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VRTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649299398","title":"大摩解读福泰制药百亿收购Crinetics：补齐内分泌管线布局 两大核心药物打开增长空间","url":"https://stock-news.laohu8.com/highlight/detail?id=2649299398","media":"智通财经","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649299398?lang=zh_cn&edition=full","pubTime":"2026-07-08 20:01","pubTimestamp":1783512080,"startTime":"0","endTime":"0","summary":"摩根士丹利发布研报，对福泰制药以100亿美元收购Crinetics的交易进行解读。此次收购将为福泰制药新增第五大业务支柱——内分泌药物，补齐公司管线布局。根据公告，每股85美元的收购价格较Crinetics周一的收盘价溢价了102%。值得注意的是，摩根士丹利担任福泰制药的财务顾问，协助该公司达成收购Crinetics的协议。","market":"us","thumbnail":"https://community-static.tradeup.com/news/7870ada20f73cf52a4a0efa576cd369c","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/7870ada20f73cf52a4a0efa576cd369c"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1464871.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"大摩解读福泰制药(VRTX.US)百亿收购Crinetics：补齐内分泌管线布局 两大核心药物打开增长空间","news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00B19Z3581.USD","LU0053666078.USD","LU0882574139.USD","LU0528227936.USD","IE0002270589.USD","IAI","LU0079474960.USD","LU0058720904.USD","LU1720051017.SGD","LU1244550221.USD","LU2111349929.HKD","LU0210528500.USD","SG9999001176.USD","BBH","LU1732799900.SGD","PBE","KBWB","LU1720051108.HKD","IDNA","BK4581","LU1363072403.SGD","LU2362540622.SGD","LU2456880835.USD","LU0390134368.USD","IE00B894F039.SGD","LU0823416689.USD","BK4139","LU0267386448.USD","LU0098860793.USD","IBBQ","LU2487616109.SGD","VRTX","LU0109394709.USD","BIB","LU2237438978.USD","IE0002141913.USD","BK4533","LU2362541273.HKD","BK4588","IBB","LU0432979614.USD","LU2089284900.SGD","LU2133065610.SGD","LU1674673691.USD","LU1585245621.USD","IE0009355771.USD","IE00B19Z9P08.USD","LU2236285917.USD","IE00BZ9MQY76.HKD","LU1791710400.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649939579","title":"大摩解读福泰制药(VRTX.US)百亿收购Crinetics：补齐内分泌管线布局 两大核心药物打开增长空间","url":"https://stock-news.laohu8.com/highlight/detail?id=2649939579","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649939579?lang=zh_cn&edition=full","pubTime":"2026-07-08 19:40","pubTimestamp":1783510856,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IBB","LU1720051017.SGD","LU0314104364.USD","LU1585245621.USD","SG9999001176.USD","LU0053666078.USD","LU1244550221.USD","IE00B19Z3B42.SGD","LU2362541273.HKD","LU2133065610.SGD","IDNA","LU0795875086.SGD","BK4127","BBH","IE00B19Z9Z06.USD","LU0823416689.USD","LU2237438978.USD","LU0061475181.USD","IAI","LU2362540622.SGD","BK4139","IE00BJJMRZ35.SGD","LU2347655156.SGD","BIB","SG9999001176.SGD","LU0058720904.USD","LU1244550577.SGD","LU1074936037.SGD","LU0006306889.USD","IE00B19Z3581.USD","LU0882574139.USD","LU1430594728.SGD","VRTX","LU2487616109.SGD","LU1668664300.SGD","KBWB","LU0795875169.SGD","LU1674673428.USD","LU1548497426.USD","LU2089283258.USD","SG9999013999.USD","LU0267386448.USD","PBE","LU2271345857.HKD","LU0079474960.USD","IBBQ","LU2417539215.USD","LU2462157665.USD","BK4567","LU0417517546.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649969921","title":"RBC Capital上调福泰制药目标价至570美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2649969921","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649969921?lang=zh_cn&edition=full","pubTime":"2026-07-08 16:24","pubTimestamp":1783499090,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["IE00B4R5TH58.HKD","VRTX","IDNA","IE00BJJMRZ35.SGD","BIB","LU1778281490.HKD","LU0310800379.SGD","RY","LU0058720904.USD","SG9999001176.USD","BK4532","LU2462157665.USD","IE00B19Z9Z06.USD","LU2324357040.USD","BK4585","BBH","IE0009355771.USD","IBBQ","SG9999013999.USD","LU0029864427.USD","LU0708994859.HKD","LU1069344957.HKD","LU2237438978.USD","LU0417517546.SGD","IE00B19Z3B42.SGD","UDN","GSIB","LU1267930573.SGD","BK4567","LU0289739699.SGD","IBB","LU2456880835.USD","LU0320765992.SGD","BK4139","LU0823416689.USD","LU0234570918.USD","LU1093756325.SGD","LU0128525929.USD","IE00B19Z9P08.USD","PBE","BK4207","IE00B894F039.SGD","SGXZ57979304.SGD","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","LU2362540622.SGD","LU1093756168.USD","LU2417539215.USD","BK4533","UUP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111378876","title":"Vera Therapeutics股价飙升：肾病新药获FDA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=1111378876","media":"投资观察","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1111378876?lang=zh_cn&edition=full","pubTime":"2026-07-08 02:47","pubTimestamp":1783450047,"startTime":"0","endTime":"0","summary":"周二，Vera Therapeutics, Inc.的股价上涨约8%，此前美国食品药品监督管理局批准了其用于治疗IgA肾病的药物。这款名为Trutakna的药物通过阻断两种蛋白质来发挥作用，这两种蛋白质会促使免疫系统产生抗体，这些抗体在肾脏中积聚并造成损伤。这是美国首个获批同时靶向这两种蛋白质的药物，尽管已有其他几种药物治疗该疾病。福泰制药正在研发一种同样能阻断这两种蛋白质的类似药物，FDA预计将在今年晚些时候对此做出裁决。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2362541513.USD","LU0889565916.HKD","IE00B19Z9P08.USD","SG9999001176.SGD","LU2456880835.USD","LU0320765992.SGD","LU0823416689.USD","SGXZ57979304.SGD","BK4139","IE00B19Z3B42.SGD","BK4532","BK4533","BK4567","LU1674673428.USD","LU2462157665.USD","LU1035775433.USD","SG9999001176.USD","LU0417517546.SGD","IE0009355771.USD","IE00BZ9MQY76.HKD","BK4585","IE00BJJMRZ35.SGD","LU1093756325.SGD","LU1430594728.SGD","BIB","IE00B4R5TH58.HKD","IE0002270589.USD","IE00BFTCPJ56.SGD","LU0058720904.USD","LU0289739699.SGD","LU2362540622.SGD","IBBQ","VERA","LU0256863811.USD","VRTX","LU0061475181.USD","LABU","PBE","IE00B19Z9Z06.USD","IE0002141913.USD","LU0432979614.USD","IBB","LU0079474960.USD","IE00BJT1NW94.SGD","BBH","IDNA","BK4539","LU0109394709.USD","LU1069344957.HKD","LU0234570918.USD","LU1093756168.USD","LU2417539215.USD","LU2236285917.USD","SG9999013999.USD","IE00B2B36J28.USD","LU1674673691.USD","LU1585245621.USD","LU1778281490.HKD","BK4588","IE00B19Z3581.USD","IE00B894F039.SGD","LU2362541273.HKD","LU2237438978.USD","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161465425","title":"暴涨近99%！Crinetics获福泰制药拟100亿美元现金收购","url":"https://stock-news.laohu8.com/highlight/detail?id=1161465425","media":"老虎资讯综合","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1161465425?lang=zh_cn&edition=full","pubTime":"2026-07-07 21:52","pubTimestamp":1783432357,"startTime":"0","endTime":"0","summary":"7月7日，Crinetics美股盘中大幅上涨，涨近99%。消息面上，福泰制药同意以约100亿美元现金收购Crinetics，每股收购价为85美元，较Crinetics周一收盘价溢价约102%。受交易影响，福泰制药股价跌超2%。","market":"us","thumbnail":"https://community-static.tradeup.com/news/ce70f982c0b1f1a2ba3407f02bcf893f","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/ce70f982c0b1f1a2ba3407f02bcf893f"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRNX","VRTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649708736","title":"100亿美元砸出史上最大收购：福泰制药(VRTX.US)溢价100%收购Crinetics(CRNX.US)，杀入内分泌赛道","url":"https://stock-news.laohu8.com/highlight/detail?id=2649708736","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649708736?lang=zh_cn&edition=full","pubTime":"2026-07-07 08:35","pubTimestamp":1783384535,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1430594728.SGD","BK4533","IE00BJT1NW94.SGD","VRTX","LU0320765992.SGD","LU0234570918.USD","LU2362541273.HKD","IDNA","LU0432979614.USD","LU0889565916.HKD","LU0079474960.USD","BBH","BK4585","IE00B19Z9Z06.USD","LU2417539215.USD","IE00B4R5TH58.HKD","IBB","LU2456880835.USD","LU2324357040.USD","SG9999001176.USD","LU0417517546.SGD","LU0109394709.USD","LU0823416689.USD","IE00B19Z9P08.USD","IE00B2B36J28.USD","IE00B19Z3581.USD","IE00BZ9MQY76.HKD","LU0256863811.USD","LU1093756168.USD","BK4007","LU1093756325.SGD","LU1674673691.USD","LU2237438978.USD","IE0002270589.USD","LU0061475181.USD","IBBQ","LU2362540622.SGD","SGXZ57979304.SGD","LU1035775433.USD","LU0289739699.SGD","BIB","CRNX","BK4139","IE00BJJMRZ35.SGD","PBE","LU1778281490.HKD","LU0058720904.USD","BK4588","LU1585245621.USD","SG9999001176.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198601451","title":"福泰制药拟斥资100亿美元收购Crinetics制药公司","url":"https://stock-news.laohu8.com/highlight/detail?id=1198601451","media":"老虎资讯综合","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1198601451?lang=zh_cn&edition=full","pubTime":"2026-07-07 06:13","pubTimestamp":1783376037,"startTime":"0","endTime":"0","summary":"7月7日，Vertex制药公司周一宣布，将以每股$85.00的现金价格收购Crinetics制药公司，交易总股权价值约为100亿美元，扣除预计所获现金后净值约为88亿美元。消息公布后，Crinetics盘后股价飙升近100%。两家公司董事会均已一致批准此次交易。交易预计于2026年第三季度完成，尚需满足惯常交割条件，包括获得监管机构批准及Crinetics股东批准。Crinetics旗下产品PALSONIFY已于2025年9月获得美国食品药品监督管理局批准，近期亦获欧洲药品管理局批准上市。","market":"us","thumbnail":"https://static.tigerbbs.com/e68f18a297e419bae3cc0320b6d8ff4e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/e68f18a297e419bae3cc0320b6d8ff4e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":"福泰制药拟斥资100亿美元收购Crinetics制药公司","news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VRTX","CRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159544198","title":"SEC文件披露：特定情况下交易终止，Crinetics Pharmaceuticals或需向福泰制药支付3.5047亿美元解约费","url":"https://stock-news.laohu8.com/highlight/detail?id=1159544198","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1159544198?lang=zh_cn&edition=full","pubTime":"2026-07-07 05:22","pubTimestamp":1783372928,"startTime":"0","endTime":"0","summary":"根据一份提交给美国证券交易委员会的文件披露，Crinetics Pharmaceuticals Inc. 与福泰制药之间的交易若在特定情况下被终止，前者可能需要向后者支付高达3.5047亿美元的终止费用。该文件明确了触发这一巨额财务义务的具体情形。协议条款显示，这笔费用的支付并非自动生效，而是与特定的终止条件紧密挂钩。然而，这也同时意味着，一旦协议因规定情形破裂，Crinetics Pharmaceuticals将面临显著的财务支出。目前，市场正密切关注两家公司后续的动向以及该交易的具体进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999013999.USD","IE00B19Z9Z06.USD","LU1585245621.USD","LU1674673691.USD","BBH","IBBQ","BK4567","IE00B894F039.SGD","LU0889565916.HKD","IE00B19Z3B42.SGD","IE00B2B36J28.USD","LU0109394709.USD","BK4007","LU2237438978.USD","LU1035775433.USD","IE00B4R5TH58.HKD","LU1093756168.USD","LU1674673428.USD","IE00BJT1NW94.SGD","LU2456880835.USD","PBE","IE00BFTCPJ56.SGD","IDNA","LU0058720904.USD","BK4139","LU1778281490.HKD","VRTX","LU2417539215.USD","BK4585","LU0432979614.USD","LU0079474960.USD","IE00B19Z3581.USD","LU0289739699.SGD","IE0002141913.USD","LU0417517546.SGD","SGXZ57979304.SGD","LU1069344957.HKD","LU2362541273.HKD","BK4533","LU2324357040.USD","LU2362540622.SGD","IE00B19Z9P08.USD","LU0061475181.USD","LU0320765992.SGD","LU2462157665.USD","SG9999001176.SGD","LU0256863811.USD","BK4588","SG9999001176.USD","IE00BZ9MQY76.HKD","LU2362541513.USD","LU2236285917.USD","LU0234570918.USD","CRNX","IBB","IE0009355771.USD","IE00BJJMRZ35.SGD","BK4532","LU0823416689.USD","LU1093756325.SGD","BIB","LU1430594728.SGD","IE0002270589.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649679149","title":"生物制药公司Crinetics盘后涨超100%福泰制药将以85美元/股收购公司。","url":"https://stock-news.laohu8.com/highlight/detail?id=2649679149","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649679149?lang=zh_cn&edition=full","pubTime":"2026-07-07 04:09","pubTimestamp":1783368555,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["SG9999013999.USD","IE00B19Z9P08.USD","LU2324357040.USD","LU2362540622.SGD","BBH","UUP","BK4588","MRNY","LU2236285917.USD","IE00BJJMRZ35.SGD","BK4585","LU2237438978.USD","IE00B19Z3581.USD","LU0289739699.SGD","IBB","BK4139","SGXZ57979304.SGD","IE00B19Z9Z06.USD","UDN","LU2417539215.USD","LU0320765992.SGD","BK4567","IE00BJT1NW94.SGD","LU2362541273.HKD","MRNX","LU1585245621.USD","LU1093756325.SGD","LU2462157665.USD","LU1778281490.HKD","IBBQ","LU0079474960.USD","LU0823416689.USD","BK4533","LU0061475181.USD","IE0002141913.USD","LU1093756168.USD","IDNA","PBE","BIB","LU2456880835.USD","BBP","VRTX","IE00BFTCPJ56.SGD","LU1035775433.USD","LU1674673691.USD","IE00B2B36J28.USD","BK4532","SG9999001176.USD","LU2362541513.USD","LU1674673428.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127833937","title":"Crinetics与福泰制药交易预计2029年提升后者非GAAP运营收入","url":"https://stock-news.laohu8.com/highlight/detail?id=1127833937","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1127833937?lang=zh_cn&edition=full","pubTime":"2026-07-07 04:07","pubTimestamp":1783368452,"startTime":"0","endTime":"0","summary":"根据最新披露的财务预测，Crinetics Pharmaceuticals Inc. 与福泰制药达成的战略合作，预计将在2029年对福泰制药的非通用会计准则运营收入产生积极贡献。\n此次交易的结构设计旨在通过长期协同效应，增强福泰制药的盈利质量。分析指出，该合作不仅将拓展福泰制药在特定治疗领域的产品管线，还可能优化其整体运营效率。市场预期，随着合作项目进入成熟阶段，其对财务指标的正面影响将逐步显现。\n财务模型显示，此次合作带来的收入增长与成本协同效应，是推动非通用会计准则运营收入提升的关键因素。投资者正密切关注交易细节及后续整合进程，以评估其长期价值创造潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","LU1778281490.HKD","BK4588","IE00B19Z3581.USD","LU0823416689.USD","LU2456880835.USD","IE0002141913.USD","IE0002270589.USD","IE00B2B36J28.USD","BBH","LU2362541273.HKD","BK4585","LU0256863811.USD","LU1069344957.HKD","LU1093756168.USD","LU2417539215.USD","CRNX","LU0417517546.SGD","LU2236285917.USD","LU1585245621.USD","LU0234570918.USD","LU0061475181.USD","LU1093756325.SGD","IBB","LU2237438978.USD","LU0289739699.SGD","LU1674673691.USD","IE00B4R5TH58.HKD","LU2362540622.SGD","IE00BJT1NW94.SGD","IE00BZ9MQY76.HKD","LU0432979614.USD","LU2462157665.USD","SG9999001176.SGD","VRTX","SGXZ57979304.SGD","LU1674673428.USD","IE00B894F039.SGD","IE00BFTCPJ56.SGD","IE00B19Z3B42.SGD","IBBQ","LU2362541513.USD","BK4007","BK4139","LU0889565916.HKD","BK4533","BIB","SG9999013999.USD","IDNA","SG9999001176.USD","PBE","IE00B19Z9Z06.USD","LU2324357040.USD","LU0320765992.SGD","LU1430594728.SGD","IE00BJJMRZ35.SGD","BK4532","LU1035775433.USD","IE0009355771.USD","IE00B19Z9P08.USD","BK4567","LU0079474960.USD","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179291339","title":"Crinetics Pharmaceuticals：融资获美国银行与摩根士丹利的45亿美元全额承诺过桥贷款支持","url":"https://stock-news.laohu8.com/highlight/detail?id=1179291339","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1179291339?lang=zh_cn&edition=full","pubTime":"2026-07-07 04:06","pubTimestamp":1783368378,"startTime":"0","endTime":"0","summary":"Crinetics Pharmaceuticals Inc. 的融资计划，已获得来自美国银行和摩根士丹利高级融资部门提供的总额高达45亿美元的全额承诺过桥贷款支持。这笔资金将为公司的战略推进提供坚实的财务后盾。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0289739699.SGD","SG9999001176.USD","LU1093756168.USD","IE00BJT1NW94.SGD","LU1093756325.SGD","LU2237438978.USD","LU2362541513.USD","VRTX","IE00BFTCPJ56.SGD","LU0061475181.USD","CRNX","LU2456880835.USD","LU0079474960.USD","LU0234570918.USD","BK4588","IDNA","IE00B19Z3B42.SGD","LU2417539215.USD","LU1674673428.USD","BK4532","LU1585245621.USD","LU2324357040.USD","BK4139","LU0256863811.USD","IE00BZ9MQY76.HKD","IE00B2B36J28.USD","LU1778281490.HKD","BBH","BK4585","SG9999001176.SGD","LU0109394709.USD","LU1035775433.USD","IBBQ","LU1069344957.HKD","BK4533","BIB","IE0002141913.USD","LU1674673691.USD","LU2362540622.SGD","IE00B19Z9Z06.USD","LU0320765992.SGD","IBB","PBE","IE00B894F039.SGD","LU2462157665.USD","IE00B19Z3581.USD","LU0889565916.HKD","IE0002270589.USD","LU2362541273.HKD","SGXZ57979304.SGD","LU0417517546.SGD","SG9999013999.USD","LU0432979614.USD","LU0823416689.USD","BK4007","IE0009355771.USD","BK4567","IE00BJJMRZ35.SGD","LU0058720904.USD","LU2236285917.USD","IE00B4R5TH58.HKD","LU1430594728.SGD","IE00B19Z9P08.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154393441","title":"福泰制药就囊性纤维化疗法Alyftrek与泛加拿大药品联盟签署意向书","url":"https://stock-news.laohu8.com/highlight/detail?id=1154393441","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1154393441?lang=zh_cn&edition=full","pubTime":"2026-07-06 22:25","pubTimestamp":1783347947,"startTime":"0","endTime":"0","summary":"福泰制药与泛加拿大药品联盟就囊性纤维化治疗药物Alyftrek的潜在合作签署了意向书。此举标志着该药物在加拿大市场准入进程中的一个重要步骤，旨在为患者提供新的治疗选择。意向书的签署为后续正式协议的谈判奠定了基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2236285917.USD","IE00B19Z9Z06.USD","LU0109394709.USD","IE00B4R5TH58.HKD","IE0002270589.USD","IBBQ","PBE","LU1069344957.HKD","LU0079474960.USD","LU0256863811.USD","SGXZ57979304.SGD","LU1093756168.USD","BK4585","LU0058720904.USD","LU0234570918.USD","LU1778281490.HKD","IE00BJT1NW94.SGD","IE0009355771.USD","LU2362541273.HKD","LU2456880835.USD","BK4533","IBB","LU2417539215.USD","LU2237438978.USD","LU0320765992.SGD","IE00B894F039.SGD","LU2462157665.USD","LU1674673428.USD","LU2362540622.SGD","VRTX","LU1585245621.USD","LU2324357040.USD","SG9999013999.USD","IE00BZ9MQY76.HKD","BK4139","BK4532","LU0432979614.USD","BIB","IE00B19Z3581.USD","LU1674673691.USD","IE00B19Z9P08.USD","IE00BFTCPJ56.SGD","BBH","IE00BJJMRZ35.SGD","LU0889565916.HKD","LU2362541513.USD","LU1430594728.SGD","LU0417517546.SGD","BK4588","IE0002141913.USD","IDNA","BK4567","IE00B19Z3B42.SGD","LU0289739699.SGD","LU0061475181.USD","LU0823416689.USD","IE00B2B36J28.USD","LU1035775433.USD","LU1093756325.SGD","SG9999001176.SGD","SG9999001176.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181069392","title":"异动解读｜福泰制药盘中上涨3.25%，FDA批准Casgevy适用年龄下限降至两岁","url":"https://stock-news.laohu8.com/highlight/detail?id=1181069392","media":"行情直击","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1181069392?lang=zh_cn&edition=full","pubTime":"2026-07-02 22:09","pubTimestamp":1783001394,"startTime":"0","endTime":"0","summary":"7月2日，福泰制药盘中上涨3.25%，报516.04美元/股，成交额8953.56万美元。消息面上，美国FDA批准福泰制药基因疗法Casgevy扩大适用人群，将最低适用年龄从12岁降至2岁，覆盖镰状细胞病伴复发性血管闭塞危象及输血依赖型β地中海贫血患儿。公司表示，此次标签扩展预计使美国约5500名额外儿童患者有资格接受这一一次性细胞疗法治疗。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VRTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648650958","title":"FDA扩大福泰(VRTX)Casgevy基因疗法适用人群 两岁及以上血液病患儿可纳入治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2648650958","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648650958?lang=zh_cn&edition=full","pubTime":"2026-07-02 18:03","pubTimestamp":1782986636,"startTime":"0","endTime":"0","summary":"Casgevy 依托 CRISPR 基因编辑技术改造患者自体造血干细胞，从根源改善血红蛋白缺陷问题，减少患者长期输血与血管闭塞危象发作频次，属于一次性治疗型细胞疗法。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250107/ZDBhOTg3YTMxNzM2MjM3OTI3ODI2.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/ZDBhOTg3YTMxNzM2MjM3OTI3ODI2.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"302133","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VRTX","SG9999001176.SGD","BK4567","LU2236285917.USD","IE00BJT1NW94.SGD","IE00B2B36J28.USD","LU0079474960.USD","BK4532","IE0009355771.USD","BK4588","LU0061475181.USD","IE00BJJMRZ35.SGD","LU2237438978.USD","LU1674673428.USD","LU0889565916.HKD","LU2362541273.HKD","LU1069344957.HKD","LU0320765992.SGD","LU1093756168.USD","LU0417517546.SGD","SG9999001176.USD","LABU","IE00B19Z3581.USD","LU0234570918.USD","LU1674673691.USD","IE0002141913.USD","BK4585","LU2362540622.SGD","IE00B19Z9Z06.USD","LU2456880835.USD","LU1585245621.USD","SGXZ57979304.SGD","LU0256863811.USD","IE00B4R5TH58.HKD","LU0432979614.USD","LU0109394709.USD","LU0058720904.USD","LU2462157665.USD","LU2362541513.USD","BK4139","LU2324357040.USD","LU1430594728.SGD","IE00BZ9MQY76.HKD","BK4533","LU0289739699.SGD","IE00B894F039.SGD","LU2417539215.USD","LU1093756325.SGD","LU1778281490.HKD","IE00BFTCPJ56.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108065974","title":"福泰制药宣布美国FDA批准扩大Casgevy®使用范围，适用于两岁及以上镰状细胞病或输血依赖型β地中海贫血患者","url":"https://stock-news.laohu8.com/highlight/detail?id=1108065974","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1108065974?lang=zh_cn&edition=full","pubTime":"2026-07-02 07:58","pubTimestamp":1782950333,"startTime":"0","endTime":"0","summary":"福泰制药宣布，其基因疗法药物Casgevy®已获得美国食品药品监督管理局的批准，将适用人群扩展至两岁及以上的镰状细胞病或输血依赖型β地中海贫血患者。这一决定标志着该疗法在更广泛的患者群体中，尤其是在年幼儿童中的应用获得了监管认可，有望为更多受这些严重血液疾病困扰的家庭带来新的治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","IE00BJJMRZ35.SGD","LU0889565916.HKD","BK4588","IE00B19Z3581.USD","LU1674673691.USD","IE00BFTCPJ56.SGD","BK4567","LU0289739699.SGD","LU1585245621.USD","BK4139","SG9999001176.USD","LU0061475181.USD","LU2456880835.USD","LU1093756168.USD","IE00B19Z9Z06.USD","IE00B19Z9P08.USD","LU1674673428.USD","LU0109394709.USD","LU2362541273.HKD","SG9999013999.USD","IE0002270589.USD","IE00BZ9MQY76.HKD","SG9999001176.SGD","LU1093756325.SGD","BK4533","LU0058720904.USD","LU2324357040.USD","IE00BJT1NW94.SGD","IE00B4R5TH58.HKD","IE00B2B36J28.USD","LU1035775433.USD","BK4532","LU0079474960.USD","LU2236285917.USD","IE0002141913.USD","LU0417517546.SGD","LU2362540622.SGD","LU0256863811.USD","LU1069344957.HKD","LU2362541513.USD","IE0009355771.USD","LU0432979614.USD","LU0823416689.USD","LU2417539215.USD","SGXZ57979304.SGD","LU1430594728.SGD","LU1778281490.HKD","IE00B19Z3B42.SGD","LU2462157665.USD","LU2237438978.USD","LU0320765992.SGD","LU0234570918.USD","IE00B894F039.SGD","VRTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138228464","title":"异动解读｜福泰制药盘中上涨3.26%，多重管线利好持续催化","url":"https://stock-news.laohu8.com/highlight/detail?id=1138228464","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1138228464?lang=zh_cn&edition=full","pubTime":"2026-06-26 22:31","pubTimestamp":1782484263,"startTime":"0","endTime":"0","summary":"6月26日，福泰制药盘中上涨3.26%，报498.355美元/股，成交额1.73亿美元。消息面上，公司近期利好密集释放：6月11日在欧洲血液学协会大会公布Casgevy基因编辑疗法针对5至11岁儿童的三期数据，全部患者实现无血管闭塞危象或脱离输血依赖；此前美国FDA已正式受理Povetacicept治疗IgA肾病的生物制品许可申请，进入加速批准通道。叠加当日生物科技板块整体走强，Moderna涨11.18%、吉利德科学涨3.0%、艾伯维涨2.59%，行业情绪共振推动个股上行。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VRTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645819136","title":"基因编辑概念普升 安捷伦科技(A)领涨4.21% 机构指美国FDA相关疗法审评新规利好相关标的","url":"https://stock-news.laohu8.com/highlight/detail?id=2645819136","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645819136?lang=zh_cn&edition=full","pubTime":"2026-06-24 22:21","pubTimestamp":1782310862,"startTime":"0","endTime":"0","summary":"金吾财讯 | 美股基因编辑概念普升，截至发稿，安捷伦科技 (A) 涨 4.21%，Beam Therapeutics (BEAM) 涨 3.55%，Intellia Therapeutics (NTLA) 涨 2.95%，Editas Medicine (EDIT) 涨 2.17%，福泰制药 (VRTX) 涨 1.28%。消息面上，建银国际新近研究认为，美国FDA近期发布了基因编辑疗法审评新规，允许药企在提供充分科学可比性论证的前提下，引用“先验知识”或既往成熟研究数据以加速研发，此举这标志着基因编辑疗法审评思路的重要转变，直接利好拥有相关技术平台的企业。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250107/NDViNTE0MThlOGIzNGVjYjVmZmFmNTJlOTIxNzAyOTY1ODYyNw==.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/NDViNTE0MThlOGIzNGVjYjVmZmFmNTJlOTIxNzAyOTY1ODYyNw==.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"301875","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJT1NW94.SGD","LU2229751404.USD","LU0432979614.USD","IE00BN0W2V16.EUR","SGXZ57979304.SGD","LU2041044095.USD","VRTX","LU2413666699.HKD","BK4567","BK4611","IE00BZ9MQY76.HKD","BK4139","LU1035775433.USD","IE00B19Z9Z06.USD","LU2236285917.USD","LU2089279066.USD","LU0079474960.USD","LU2462157665.USD","LU1861558580.USD","IE00BJJMRZ35.SGD","EDIT","LU2092937221.SGD","A","LU1861559042.SGD","LU1674673428.USD","LU0058720904.USD","LU1674673691.USD","BK4121","IE00BN0W2W23.USD","IE00BFTCPJ56.SGD","LABU","LU0234570918.USD","LU0889565916.HKD","LU2362540622.SGD","SG9999001176.SGD","NTLA","LU2324357040.USD","BK4505","IE00B19Z3581.USD","SG9999013999.USD","LU2362541273.HKD","BK4533","LU1585245621.USD","LU0417517546.SGD","BK4588","BEAM","LU0256863811.USD","LU0320765992.SGD","IE00B894F039.SGD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.vrtx.com","stockEarnings":[{"period":"1week","weight":-0.0171},{"period":"1month","weight":0.0045},{"period":"3month","weight":0.1094},{"period":"6month","weight":0.0191},{"period":"1year","weight":0.0108},{"period":"ytd","weight":0.0529}],"compareEarnings":[{"period":"1week","weight":-0.0059},{"period":"1month","weight":0.0078},{"period":"3month","weight":0.035},{"period":"6month","weight":0.0721},{"period":"1year","weight":0.1647},{"period":"ytd","weight":0.0836}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Vertex Pharmaceuticals Incorporated于1989年在马萨诸塞州注册成立，是一家全球性的生物技术公司，致力于科学创新，旨在为患有严重疾病的个人，特别是在专业市场创造变革性药物。该公司已开发出针对囊性纤维化、镰状细胞病、输血依赖性β地中海贫血和急性疼痛等病症的获批疗法。该公司不断创新，推进跨越各种严重疾病的下一代临床和研究项目，包括IgA肾病和1型糖尿病等。","yearOnYearQuotes":[{"month":1,"riseRate":0.657143,"avgChangeRate":0.034393},{"month":2,"riseRate":0.457143,"avgChangeRate":0.001601},{"month":3,"riseRate":0.428571,"avgChangeRate":-0.021959},{"month":4,"riseRate":0.6,"avgChangeRate":0.01636},{"month":5,"riseRate":0.571429,"avgChangeRate":0.076942},{"month":6,"riseRate":0.571429,"avgChangeRate":0.030748},{"month":7,"riseRate":0.457143,"avgChangeRate":-0.005604},{"month":8,"riseRate":0.628571,"avgChangeRate":0.046325},{"month":9,"riseRate":0.485714,"avgChangeRate":0.030192},{"month":10,"riseRate":0.542857,"avgChangeRate":0.000856},{"month":11,"riseRate":0.485714,"avgChangeRate":-0.02026},{"month":12,"riseRate":0.657143,"avgChangeRate":0.071588}],"exchange":"NASDAQ","name":"福泰制药","nameEN":"Vertex Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"福泰制药(VRTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供福泰制药(VRTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"福泰制药,VRTX,福泰制药股票,福泰制药股票老虎,福泰制药股票老虎国际,福泰制药行情,福泰制药股票行情,福泰制药股价,福泰制药股市,福泰制药股票价格,福泰制药股票交易,福泰制药股票购买,福泰制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"福泰制药(VRTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供福泰制药(VRTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}